Can graft endothelial cells initiate a host anti-graft immune response?
about
Endothelial cells present antigens in vivoTargeting the intragraft microenvironment and the development of chronic allograft rejectionVascular endothelium as a target of immune response in renal transplant rejectionRegulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cellsIntravital microscopy identifies selectins that regulate T cell traffic into allografts.Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.The endothelium in atherogenesis.Rejection of peritubular capillaries in renal allo- and xeno-graft.Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.Cytokines in sickle cell disease.Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsCirculating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection.Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomesFate of endothelialized modular constructs implanted in an omental pouch in nude rats.Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationThe role of non-hematopoietic stromal cells in the persistence of inflammation.Vascularized composite allograft-specific characteristics of immune responses.Hyperbaric oxygen therapy and liver transplantation.Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection.Multiparameter flow cytometric approach for simultaneous evaluation of T lymphocyte-endothelial cell interactions.Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.Role of endothelial cells in allograft rejection.Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells.Endothelial cell activation. A central pathophysiological process.Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro.Procurement regimens to reduce ischemia reperfusion injury of vascular grafts.Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses.Selective depletion of alloreactive T cells leads to long-term islet allograft survival across a major histocompatibility complex mismatch in diabetic mice.Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits.The pathophysiology of acute graft-versus-host disease.
P2860
Q24805981-4FD17951-6FA2-4060-80BB-5170C220F7B4Q26852762-31B8339B-5560-4F2F-89FC-0B8FBF5EC245Q27024077-8155B6C6-EE7C-4FFB-BC17-F1821FF6A473Q28293461-BFFB4908-D264-40F0-8C5B-A4DD37498308Q30492994-1AE2CEA3-A0E4-41B8-BD3F-26A0404171F2Q33658817-6A0BB87E-BE63-44D5-872A-B7792B992EF2Q33915443-AE90D52D-52E4-451E-944E-9707FFEFC97EQ34090393-F13193B4-AEDF-4163-82E1-B43611CF4EE6Q35124252-0A16D903-0F15-4239-B5E5-9A100DC3622EQ35552533-27589D5D-86A6-451C-9B22-D6B2B6D5D6E7Q35753285-F4C0DEE3-298A-42DB-9CBF-7A539ACA7D9BQ36375227-C80DA1ED-388C-4C65-81D8-95F5398B06DAQ36453843-25319FC3-31B0-4788-8E1C-411B7654BAD6Q36684948-47B13E5F-EDA3-443E-BFCB-5848948CE8D0Q36843420-0A80EFD4-1263-46F6-86D6-CC5C584FA906Q37070704-6BCD91A4-231E-4F74-938C-5C55459784D7Q37471374-D8227688-2007-423A-B669-F84325E1008EQ38008362-78F0D7E2-B48D-4786-9AB1-3D4F56A10BC2Q38075556-5226FF87-4713-466D-9E15-E09E772477FBQ38755493-21D93A55-E51F-4029-BA43-496FFF35BDEFQ39721640-2C8FAD6E-3439-4225-87D6-DA9FD3937A23Q39800052-34387E99-EA95-4512-BF90-01A8C45DABECQ40762995-F393BACB-0FD6-4C1A-B631-863BA64D5063Q40959666-D9A413E8-EF15-4561-8BF3-6FEA502171B6Q41740428-074C1288-9468-4DC2-90C3-82E91128E35DQ42236685-802278F0-ADAC-4D0A-B7AD-C9FE4666CB5EQ42756818-622005ED-6C72-48B7-AA42-5B67D4FCA1F9Q42934189-B1E55E6E-01E1-48C4-A061-5F2AF5CAD262Q44117675-4AA61B84-A55F-4907-A548-9A5214578130Q44134414-6692BB76-F1EE-4CE0-B4C8-89D1F96C2D4BQ44188868-A0487262-D1B5-41BE-B61A-487D001F227BQ50458797-4D3E34E1-EB6B-4E27-854B-3EC8C79451CAQ53676885-A917D0B1-4EEA-424E-9B85-73A291E37FEB
P2860
Can graft endothelial cells initiate a host anti-graft immune response?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Can graft endothelial cells initiate a host anti-graft immune response?
@en
type
label
Can graft endothelial cells initiate a host anti-graft immune response?
@en
prefLabel
Can graft endothelial cells initiate a host anti-graft immune response?
@en
P2093
P1433
P1476
Can graft endothelial cells initiate a host anti-graft immune response?
@en
P2093
P304
P356
10.1097/00007890-199602150-00001
P577
1996-02-01T00:00:00Z